Clinical trial Recruiting at 2 sites Interventional Ages 18 to 90

Tech-assisted relapse prevention for substance use disorders

Official title: Prevention of Relapse in Behavioral Disorders: Study Protocol of a Randomized Control Trial

Run by Clínica Nuestra Señora de la Paz · NCT07052175 · Data updated 2026-11-12

A digital monitoring tool is being tested to see if it helps people with substance use disorders stay in recovery longer when added to standard multidisciplinary treatment.

Quick facts

Study typeInterventional
Ages18 Years to 90 Years
SexAll
Enrollment150 (estimated)
SponsorClínica Nuestra Señora de la Paz
Academic / other
Locations2 sites (Ciempozuelos, Madrid and 1 other locations)
StatusRecruiting
StartedApril 1, 2026
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedMay 14, 2026
Trial IDNCT07052175 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with substance use disorders who speak Spanish, own a smartphone with internet access, and can provide informed consent.

Probably not a fit

Individuals who do not have access to compatible mobile devices or cannot comply with app installation or informed consent requirements may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study compares the usual multidisciplinary treatment for substance use disorders with an enhanced program that includes a digital monitoring tool. It is a longitudinal quasi-experimental design enrolling about 150 participants who use alcohol, cocaine, or other stimulants. The primary aim is to see if the digital tool improves relapse detection, reduces withdrawal symptoms and cravings, and improves emotional and psychosocial functioning, with patient satisfaction also measured. Outcomes will be assessed using validated instruments over time to determine added clinical value. The study focuses on real-world implementation and feasibility across two Madrid-area centers.

Why it matters

Potential benefit: If successful, the digital tool could enable earlier relapse interventions and improve long-term recovery outcomes.

How similar studies have gone: Previous work in digital health for addiction care has shown promise, but this specific combination of a digital monitoring tool with a standard multidisciplinary model is being tested for added value.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Understand spoken and written Spanish.
* Signing the informed consent.
* Own a smartphone with internet access and an iOS or Android operating system.

Exclusion Criteria:

* Institutionalized or incarcerated patients, or those anticipating imminent incarceration, without regular access to mobile phone use.
* Refusal to install the mobile application.
* Inability to understand and sign the informed consent form for any reason.

Where it's running

  • Centro de San Juan de Dios de Ciempozuelos
    Ciempozuelos, Madrid, Spain
    Recruiting
  • Clínica Nuestra Señora de la Paz
    Madrid, Madrid, Spain
    Recruiting

Study contacts

  • Principal investigator: Juan Jesús Muñoz García, PhD — Centro San Juan de Dios de Ciempozuelos
  • Study coordinator: Rafael Salom Borrás, PhD
  • Email: rafael.salom@sjd.es
  • Phone: +34 914 15 60 00

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.